155 related articles for article (PubMed ID: 17308683)
21. Reproducible and clinically meaningful differential diagnosis is possible between lobular endocervical glandular hyperplasia and 'adenoma malignum' based on common histopathological criteria.
Tsuda H; Mikami Y; Kaku T; Hasegawa T; Akiyama F; Ohishi Y; Sasajima Y; Kasamatsu T
Pathol Int; 2005 Jul; 55(7):412-8. PubMed ID: 15982216
[TBL] [Abstract][Full Text] [Related]
22. Immunohistochemical studies on carcinoembryonic antigen in adenocarcinomas of the uterus.
Ueda S; Tsubura A; Izumi H; Sasaki M; Morii S
Acta Pathol Jpn; 1983 Jan; 33(1):59-69. PubMed ID: 6340419
[TBL] [Abstract][Full Text] [Related]
23. Villoglandular adenocarcinoma of the cervix: two new cases with morphological and molecular study.
Giordano G; D'Adda T; Gnetti L; Merisio C; Gabrielli M; Melpignano M
Int J Gynecol Pathol; 2007 Apr; 26(2):199-204. PubMed ID: 17413990
[TBL] [Abstract][Full Text] [Related]
24. Immunohistochemical localization of carcinoembryonic antigen in microglandular hyperplasia and adenocarcinoma of the endocervix.
Speers WC; Picaso LG; Silverberg SG
Am J Clin Pathol; 1983 Jan; 79(1):105-7. PubMed ID: 6336881
[TBL] [Abstract][Full Text] [Related]
25. Endocervical adenocarcinomas with prominent endometrial or endomyometrial involvement simulating primary endometrial carcinomas: utility of HPV DNA detection and immunohistochemical expression of p16 and hormone receptors to confirm the cervical origin of the corpus tumor.
Yemelyanova A; Vang R; Seidman JD; Gravitt PE; Ronnett BM
Am J Surg Pathol; 2009 Jun; 33(6):914-24. PubMed ID: 19295407
[TBL] [Abstract][Full Text] [Related]
26. Value of tumor markers in diagnosing and monitoring colorectal cancer and strategies for further improvement: analysis of 130 cases.
Chen C; Chen LQ; Yang GL; Li Y
Ai Zheng; 2007 Nov; 26(11):1221-6. PubMed ID: 17991322
[TBL] [Abstract][Full Text] [Related]
27. [Analysis of the levels of CA125, CA19-9, and CEA in the cervical mucus helps a diagnosis of cervical adenocarcinomas].
Fujii S; Konishi I; Nanbu Y; Sagawa N; Nonogaki H; Mori T
Nihon Sanka Fujinka Gakkai Zasshi; 1987 Dec; 39(12):2193-4. PubMed ID: 3480920
[No Abstract] [Full Text] [Related]
28. Immunohistochemical comparison of new monoclonal antibody 1C5 and carcinoembryonic antigen in the differential diagnosis of adenocarcinoma of the uterine cervix.
Kudo R; Sasano H; Koizumi M; Orenstein JM; Silverberg SG
Int J Gynecol Pathol; 1990; 9(4):325-36. PubMed ID: 1700970
[TBL] [Abstract][Full Text] [Related]
29. Immunohistochemistry as a diagnostic aid in cervical pathology.
McCluggage WG
Pathology; 2007 Feb; 39(1):97-111. PubMed ID: 17365826
[TBL] [Abstract][Full Text] [Related]
30. Immunohistochemical phenotype of the urinary bladder endocervicosis: comparison with normal endocervix and well-differentiated mucinous adenocarcinoma of uterine cervix.
Hao H; Tsujimoto M; Tsubamoto H; Komori S; Hirota S
Pathol Int; 2010 Jul; 60(7):528-32. PubMed ID: 20594276
[TBL] [Abstract][Full Text] [Related]
31. Endocervical adenomyoma. A case report with histochemical and immunohistochemical studies.
Mikami Y; Maehata K; Fujiwara K; Manabe T
APMIS; 2001; 109(7-8):546-50. PubMed ID: 11552953
[TBL] [Abstract][Full Text] [Related]
32. Adding the p16(INK4a) marker to the traditional 3-marker (ER/Vim/CEA) panel engenders no supplemental benefit in distinguishing between primary endocervical and endometrial adenocarcinomas in a tissue microarray study.
Han CP; Lee MY; Kok LF; Ruan A; Wu TS; Cheng YW; Tyan YS; Lin CY
Int J Gynecol Pathol; 2009 Sep; 28(5):489-96. PubMed ID: 19696622
[TBL] [Abstract][Full Text] [Related]
33. Endocervical adenocarcinoma. Immunohistochemical characterization.
Resta L; Maiorano E; Colucci GA; Faggiano F; Sabatini R; Trimigliozzi F; Martulli B; Cagnazzo G
Eur J Gynaecol Oncol; 1988; 9(5):386-9. PubMed ID: 3224609
[TBL] [Abstract][Full Text] [Related]
34. Gross features of lobular endocervical glandular hyperplasia in comparison with minimal-deviation adenocarcinoma and stage Ib endocervical-type mucinous adenocarcinoma of the uterine cervix.
Sasajima Y; Mikami Y; Kaku T; Kiyokawa T; Ohishi Y; Hamada T; Sasaki T; Fujita H; Moriya T; Kasamatsu T; Tsuda H
Histopathology; 2008 Oct; 53(4):487-90. PubMed ID: 18631191
[No Abstract] [Full Text] [Related]
35. A reappraisal of three-marker (ER/Vim/CEA), four-marker (ER/Vim/CEA/PR), and five-marker (ER/Vim/CEA/PR/p16INK4a) panels in the diagnostic distinction between primary endocervical and endometrial adenocarcinomas in a tissue microarray study.
Han CP; Lee MY; Kok LF; Wu TS; Cheng YW; Wang PH; Yue CH; Tyan YS
Arch Gynecol Obstet; 2010 May; 281(5):845-50. PubMed ID: 19847454
[TBL] [Abstract][Full Text] [Related]
36. [Minimal deviation adenocarcinoma of the uterine cervix].
Mucientes F; Cabrera J; Torres L; Klassen R
Rev Chil Obstet Ginecol; 1993; 58(5):411-4. PubMed ID: 7991864
[TBL] [Abstract][Full Text] [Related]
37. WT1, monoclonal CEA, TTF1, and CA125 antibodies in the differential diagnosis of lung, breast, and ovarian adenocarcinomas in serous effusions.
Zhu W; Michael CW
Diagn Cytopathol; 2007 Jun; 35(6):370-5. PubMed ID: 17497661
[TBL] [Abstract][Full Text] [Related]
38. [A falsely reassuring cervical smear in adenocarcinoma of the external os].
Rooker D; Baalbergen A; Helmerhorst TJ
Ned Tijdschr Geneeskd; 2008 Apr; 152(17):977-80. PubMed ID: 18549169
[TBL] [Abstract][Full Text] [Related]
39. Ki67 labelling index and p53 status indicate neoplastic nature of atypical lobular endocervical glandular hyperplasia (ALEGH).
Mikami Y; Kojima A; Kiyokawa T; Manabe T
Histopathology; 2009 Sep; 55(3):362-4. PubMed ID: 19723155
[No Abstract] [Full Text] [Related]
40. Gastric morphology and immunophenotype predict poor outcome in mucinous adenocarcinoma of the uterine cervix.
Kojima A; Mikami Y; Sudo T; Yamaguchi S; Kusanagi Y; Ito M; Nishimura R
Am J Surg Pathol; 2007 May; 31(5):664-72. PubMed ID: 17460448
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
